An observational study to characterize the patient population diagnosed with sarcopenia.
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Sarconeos (Primary)
- Indications Muscular atrophy
- Focus Adverse reactions
- Acronyms SARA-OBS
- 04 Dec 2017 According to a Biophytis media release, University Hospital of Liege, trial site has been opened.
- 30 Oct 2017 According to a Biophytits media release, recruitment has been initiated at the Jean Mayer Human Nutrition Research Center on Aging (Tufts University School of Medicine) in Boston and at The Institute on Aging (University of Florida) in Gainesville.
- 11 May 2017 According to a Biophytis media release, the company has received the approval from the US regulatory authorities for the recruitment of sarcopenia patients in this trial, and the first patient from the US has been enrolled in this trial. Roger A Fielding is the head researcher of this trial.